ArticleMedical care research and review : MCRR2020
Selection Incentives for Health Insurers in the Presence of Sophisticated Risk Adjustment.
Article in Medical care research and review : MCRR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Does Health-Based Prospective Risk Adjustment Adequately Compensate for Individuals Diagnosed With a New Chronic Disease?Medical care research and review : MCRR · 2026Article
- A critical review of the use of RThe European journal of health economics : HEPAC : health economics in prevention and care · 2025Review
- A framework for ex-ante evaluation of the potential effects of risk equalization and risk sharing in health insurance markets with regulated competition.Health economics review · 2024Review
- Scope and Incentives for Risk Selection in Health Insurance Markets With Regulated Competition: A Conceptual Framework and International Comparison.Medical care research and review : MCRR · 2024Review
- High-risk pooling for mitigating risk selection incentives in health insurance markets with sophisticated risk equalization: an application based on health survey information.BMC health services research · 2024Article
- The goal of risk equalization in regulated competitive health insurance markets.The European journal of health economics : HEPAC : health economics in prevention and care · 2023Article
- Selection Incentives in the Dutch Basic Health Insurance: To What Extent Does End-of-Life Spending Contribute to Predictable Profits and Losses for Selective Groups?Medical care research and review : MCRR · 2022Article
- How to deal with persistently low/high spenders in health plan payment systems?Health economics · 2022Article
- Limiting medical certainties? Funding challenges for German and comparable public healthcare systems due to AI prediction and how to address them.Frontiers in artificial intelligence · 2022Review
- Incorporating self-reported health measures in risk equalization through constrained regression.The European journal of health economics : HEPAC : health economics in prevention and care · 2020Article
- Global budget versus cost ceiling: a natural experiment in hospital payment reform in the Netherlands.The European journal of health economics : HEPAC : health economics in prevention and care · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article analyzes selection incentives for insurers in the Dutch basic health insurance market, which operates with community-rated premiums and sophisticated risk adjustment. Selection incentives result from the interplay of three market characteristics: possible actions by insurers, consumer response to these actions, and predictable variation in profitability of insurance contracts. After a qualitative analysis of the first two characteristics our primary objective is to identify the third. Using a combination of claims data (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.